130 related articles for article (PubMed ID: 7479593)
1. Urinary multiple marker screening for Down's syndrome.
Cuckle HS; Iles RK; Sehmi IK; Chard T; Oakey RE; Davies S; Ind T
Prenat Diagn; 1995 Aug; 15(8):745-51. PubMed ID: 7479593
[TBL] [Abstract][Full Text] [Related]
2. Urinary beta-core human chorionic gonadotrophin: a new approach to Down's syndrome screening.
Cuckle HS; Iles RK; Chard T
Prenat Diagn; 1994 Oct; 14(10):953-8. PubMed ID: 7534925
[TBL] [Abstract][Full Text] [Related]
3. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
Spencer K; Aitken DA; Macri JN; Buchanan PD
Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
5. First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K; Noble P; Snijders RJ; Nicolaides KH
Prenat Diagn; 1997 Jun; 17(6):525-38. PubMed ID: 9203211
[TBL] [Abstract][Full Text] [Related]
6. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
7. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
8. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
[TBL] [Abstract][Full Text] [Related]
9. Four-marker serum screening for Down's syndrome.
Wald NJ; Densem JW; Smith D; Klee GG
Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
[TBL] [Abstract][Full Text] [Related]
11. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
12. Antenatal screening for Down's syndrome.
Wald NJ; Kennard A; Hackshaw A; McGuire A
J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
[TBL] [Abstract][Full Text] [Related]
13. Urinary beta-core hCG: screening for aneuploidies in early pregnancy (11-14 weeks' gestation).
Macintosh MC; Nicolaides KH; Noble P; Chard T; Gunn L; Iles R
Prenat Diagn; 1997 May; 17(5):401-5. PubMed ID: 9178313
[TBL] [Abstract][Full Text] [Related]
14. Urinary analysis for Down's syndrome: is the measurement of urinary beta-core the future of biochemical screening for Down's syndrome.
Iles RK
Early Hum Dev; 1996 Dec; 47 Suppl():S41-5. PubMed ID: 9031839
[TBL] [Abstract][Full Text] [Related]
15. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
Wald NJ; George L; Smith D; Densem JW; Petterson K
Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
[TBL] [Abstract][Full Text] [Related]
16. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
17. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
18. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
Spencer K; Salonen R; Muller F
Prenat Diagn; 1994 Jul; 14(7):537-42. PubMed ID: 7526363
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy.
Canick JA; Kellner LH; Saller DN; Palomaki GE; Walker RP; Osathanondh R
Prenat Diagn; 1995 Aug; 15(8):739-44. PubMed ID: 7479592
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
